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We have recently observed that (+)-palmitylcarnitine stimulates 
fatty acid synthesis by liver supernatant fractions prepared from either 
fed or starved rats (Fritz and Hsu, 1966). One of the possible mechanisms 
by which (+)-palmitylcarnitine could restore lipogenesis by livers from 
starved animals to normal levels would include a release from an inhibi- 
tion of fatty acid synthesis by a "physiological" inhibitor such as palmi- 
tyl CoA (Bortz and Lynen, 1963), or a less well defined microsomal entity 
described by Masoro et al (1962). The concentrations in liver of both 
palmityl CoA snd the microsomal inhibitor are reported by these authors to 
rise during starvation. Since palmityl CoA is also an inhibitor of citrate 
synthase activity (Wielsnd et al, 1@64; Tubbs, 1963; Srere, 1965), and 
since citrate is involved in several aspects of fatty acid metabolism 
(Srere and Bhaduri, 1962; Martin and Vagelos, 1962), it appeared that this 
reaction would be an interesting one to investigate in relation to the 
above possibility. Accordingly, citrate synthase (E. C. 4. 1. 3.7) acti- 
vity was asssyed in the presence and absence of palmityl CoA, and various 
chain-length acylcarnitine derivatives were incubated with the enzyme during 
these procedures. Results to be presented demonstrate that long-chain 
0-acylcarnitine derivatives protect citrate synthase from inhibition by pal- 
mityl CoA if they are incubated with enzyme during the incubation period 
prior to oxaloacetate addition. 
METRODS 
Citrate synthase was purchased from Boehringer Mannheim Corporation, 
and activity was assayed by following the absorbance decrease at 232 w 
indicative of thioester cleavage after the addition of oxaloacetate to 
cuvettes containing acetyl CoA and enzyme together with various components 
ms work was supported by a grant (AM-01465) from the National Institutes 
of Health. 
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listed in Results. PsJmityl CoA was prepared by the method of Seubert 
(19@)., and wa8 also purchased frcsn Sigma Biochemicals. (+)- ana (-)-Pal- 
mitylcarnitine were generous gifts from Professor E. Strack, Leipzig. 
Variou,s DL-acylcarnitine derivatives were prepared either as previously 
described (Fritz and Yue, 1963), or by method8 of Brmner (1962). A semple 
of purified a-ketoglutarate aehydrogenase was generously provided by 
Dr. Vincent Massey, and enzyme activity wae assayed by his procedures 
(Masse:y, 1960). 
RESULTS ARD DISCUSSIOlV 
Data presented in Fig. 1 confirm results of others (Wieland et al, 
1968; Tubbs, 1963; Srere, 1965) that prior incubation of palmityl CoA with 
citrate synthase inhibits enzyme activity. Adaition of acylcarnitine deri- 
vatives did not influence enzyme activity under conditions indicated when 
palmityl CoA was absent. In the presence of peJmity1 CoA, however, long- 
chain acylcarnitine derivatives offered varying degree8 of relief of inhi- 
bition, while butyrylcarnitine was without effect at concentrations employed. 
DL-octanylcsrnitine (lo-&) was associated with a slight lessening of inhi- 
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Fig. 1. Effects of various can-length acylcarnitine derivative8 on citrate 
synthase activity in the presence and absence of palmityl CoA. Crystalline 
enzyme (2 erg) was incubated for 10 minute8 at 35' with O.lM Tris- 1 buffer 
at pH 7.5, 5 erg crystall e bovine serum albumin (-our), 5 x 10' M acetyl 
% 
7 
CoA plus or minus 2 x 10' palmityl CoA and various acylcarnitine deriva- 
tives at concentrations indicated. The reaction was started by addition of 
potassium oxaloacetate to give a concentration of 5 x 10m5M in a fin8J voll8m 
0r 1.0 ml. Absorbsnce changes were followed with a Beckman spectrophotcmeter 
having a Gilford autcmatic recorder attachment, with a fIil.l scale of 0.2 
optical density units, and with the zero point adjusted to approximately 0.8 
optical density units. 
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Figs. 2 and 3. Effects of various concentrations of (+)-palmitylcaxnitine on 
citrate synthase activity in the presence of palmityl CoA. Conditions were 
the same a8 in Fig. 1 except that 50 pg albumin was present in cuvettes, and 
coanponents were incubated at 35' for only six minutes before addition of 
oxaloacetate. In Fig. 3, the percentage inhibition i8 calculated on the 
basis of iuitlal velocity measurements. 
palmityl CoA and octanyl carnitine were both present, and 81% when only 
palmityl CoA was incubated with the enzyme). Potassium paImitate with or 
without free cmitine did not influence palmityl CoA inhibition of citrate 
synthase (data not shown). 
When higher concentrations of albumin were employed, palmityl CoA 
inhibition was relieved, confirming observations of others (Wielaud et al, 
1964; Srere, 1965). Under these conditions, relatively small amounts of 
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palmitylcarnitine were required to antagonize the palmityl CoA effect 
(Figs. 2 and 3). With 50 pg albumin per ml, it was necessary to increase 
the palmityl CoA concentration to 5 x 10e5M to obtain a degree of inhibition 
comparable to that shown in Fig. 1. Either (+)- or (-)-palmitylcarnitine 
reversed palmityl CoA inhibition of citrate synthase activity, and no differ- 
ence between the two isomers could be detected. Inhibition under conditions 
defined in Fig. 3 was approximately 80$ with 50 m palmityl CoA alone, and 
only 17% when 50 @! palmityl CoA and 1.25 ~?4 (+)-palmitylcarnitine were 
present together. 
Results depicted in Figs. 2 and 3 may be interpreted by assuming that 
palmityl CoA has a greater affinity for albumin than palmitylcarnitine does, 
thereby #allowing palmitylcarnitine to be bound to citrate synthase in prefer- 
ence to palmityl CoA. It is also possible to imagine that palmitylcarnitine 
displaces palmityl CoA from specific portions of the enzyme molecule adjacent 
to the active center, and that this effect is more readily seen in the pres- 
ence of high albumin because of competition between albumin and enzyme for 
palmityl CoA. In either case, the interpretation must remain highly specula- 
tive until additional information is obtained about the mechanism of palmityl 
CoA inhibition. 
Palmitylcarnitine also relieved palmityl CoA inhibition of a-ketoglu- 
tarate dehydrogenase (Fig. 4). 
In experiments reported in an accompanying article, we have observed that 
palmityllcarnitine activated acetyl CoA carboxylase, and that it partially 
protected the enzyme from palmityl CoA inhibition under certain conditions. 
(Frite and Hsu, 1.966). Palmitylcarnitine did not prevent palmityl CoA inhi- - 
bition of two other enzymes investigated, nsmely carnitine acetyltransferase 
and monoacyl glycerophosphate transferas& (unpublished observations). 
These findings suggest that palmitylcarnitine-palmityl CoA interactions with 
various enzymes inhibited by the CoA derivative are not necessarily general. 
Pslmityl CoA inhibits a wide variety of enzymes, and it is quite possi- 
ble tha,t the effect is non-specific (Taketa and Pogell, 1.966). Similar 
conclusions have been made by Srere (1965) with respect to citrate synthase. 
Yet,palmityl CoA inhibition of this enzyme is overcome, apparently in a cam- 
petitive fashion, by oxaloacetate (Wieland et al, 1964), and these workers 
have also reportd that palmityl dephosph+CoA did not inhibit citrate syn- 
*I wish to thank Dr. W. E. M. Lands for performing experiments with this 
enzyme. 
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Fig. 4. Enzyme (25 pg) was incubated for 6 minutes at 35' with 100 m&4 phos- 
phate buffer at pH 7. 
5 
, 1 mM cr-ketoglutarate, 0. 
3 
mM DPIV, 30 mM.glutathione 
plus or minus 5 x 10' M palmityl CoA and 1 x lo- M (+)-palmitylcarnitine. 
The reaction was initiated by addition of CoA to give a concentration of 
0.054 mM in a final volume of 1.0 ml, and absorbance change at 340 mp was 
followed with a Beckman spectrophotometer having a Gilford autcmatic recorder 
attachment. 
thase. Similarly, palmityl CoA inhibition of acetyl CoA carboxylase is ccm- 
petitively overccnne by citrate (Numa et al, 1965). It is therefore possible 
that palmityl CoA inhibition of these two enzymes may prove to be of physio- 
logical importance. 
(-)-Palmitylcarnitine is known to be a substrate in the carnitine palmi- 
tyltraneferaae reaction (Fritz and Yue, 1963; Brewer, 1963; Norum, 1965). 
Until now, attention has been concentrated on the importance of this reaction 
in fatty acid oxidation (Fritz, 1963; Fritz and Marquis, 1965). While (-)- 
palmitylcarnitine serves as a reservoir for the generation of palmityl CoA 
within mitochondria, it might also play a role in antagonizing palmityl CoA 
inhibition of such enzymes as citrate synthase or acetyl CoA carboxylase. 
This latter possibility appears attractive in accounting for the stimulation 
of fatty acid synthesis by (+)-palmitylcarnitine which is examined in an 
accompanying article (Fritz and Hsu, 1966). 
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SUMMARY 
Inhibition of citrate synthase by incubation xith palmityl CoA could 
be in large part prevented by concomitant incubation of enzyme with (+)-pal- 
mitylcarnitine, (-)-palmitylcsxnitine or DL-stearylcarnitine. DL-Octanyl- 
carnitine was less effective wfiile butyrylcarnitine was without sny protec- 
tive action. The molar ratio of palmitylcarnitine to palmityl CoA required 
for relief of palmityl CoA inhibition was lowered at elevated concentrations 
of albumtn. 
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